Beckman Coulter Life Sciences is taking actions in the best interests of our associates, customers, and business partners as we navigate the growing threats of the 2019 Novel Coronavirus disease (COVID-19).Learn more
Immuno-oncology is the use of an immune-modulating agent to resolve or reverse a disease state involving cancer. Of the many modalities of immunotherapy, there is no one best suited to treat all cancer types. Instead, immuno-oncology makes use of the variety of formats of immune-modulating agents, tailoring the dosing and delivery to the unique aspects of any given cancer patient’s disease. Currently, cell-based immuno-oncology therapies are gaining traction in patient care. For more information and to learn more please navigate to our section on immuno-oncology therapeutics and CAR-T cells.
Oops. The page you wanted could not be found, so we brought you to something similar. If you still can't find what you want, try searching our site instead.